Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2023 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CITRIX SYS INC | 18 | Q3 2018 | 6.7% |
QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 3.5% |
AFFIMED N V | 16 | Q1 2019 | 1.0% |
BALL CORP | 13 | Q1 2019 | 7.2% |
RADIUS HEALTH INC | 13 | Q2 2017 | 8.4% |
TRANSDIGM GROUP INC | 11 | Q2 2016 | 10.1% |
ULTA SALON COSMETCS & FRAG I | 11 | Q4 2015 | 5.4% |
VIASAT INC | 11 | Q2 2017 | 7.5% |
AETNA INC NEW | 11 | Q2 2017 | 4.1% |
GODADDY INC | 10 | Q1 2019 | 5.7% |
View Bain Capital Public Equity Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Affimed N.V. | February 14, 2019 | 2,362,813 | 3.8% |
IMMUNE DESIGN CORP. | February 14, 2019 | 892,061 | 1.8% |
REVA Medical, Inc. | February 14, 2019 | 296,502,220 | 7.2% |
MULESOFT, INC | February 14, 2018 | 1,404,025 | 1.9% |
CONCERT PHARMACEUTICALS, INC. | February 28, 2014 | 1,147,833 | 6.7% |
IDENIX PHARMACEUTICALS INC | February 12, 2014 | 13,115,858 | 9.8% |
NORTHSTAR REALTY FINANCE CORP. | February 12, 2014 | 7,657,781 | 2.6% |
PORTOLA PHARMACEUTICALS INC | February 12, 2014 | 400,000 | 1.0% |
Dicerna Pharmaceuticals Inc | February 10, 2014 | 1,337,000 | 8.0% |
RingCentral Inc | February 07, 2014 | 471,073 | 5.5% |
View Bain Capital Public Equity Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-15 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
13F-HR | 2019-08-14 |
13F-HR | 2019-05-15 |
13F-HR | 2019-02-14 |
SC 13G/A | 2019-02-14 |
SC 13G/A | 2019-02-14 |
View Bain Capital Public Equity Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.